<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>Medical and Health Technology Project of Hangzhou</funding><funding>Zhejiang Provincial Medical and Health Technology Project</funding><pagination>243</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12080177</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Stress-induced hyperglycemia (SIH) is a common phenomenon in acute myocardial infarction and is associated with poor prognosis. The relationship between glycemic gap (GG), a marker of SIH, and ST-segment elevation myocardial infarction (STEMI)-associated acute kidney injury (STAAKI) remains unclear. This study aims to explore the predictive value of GG for the risk of STAAKI after percutaneous coronary intervention (PCI) in STEMI patients.&lt;h4>Methods&lt;/h4>This study retrospectively selected patients diagnosed with STEMI who underwent primary PCI. Logistic regression analysis was used to identify the risk factors associated with STAAKI. To examine the dose-response relationship between GG and STAAKI, restricted cubic splines (RCS) were employed. The predictive accuracy of </pubmed_abstract><journal>BMC nephrology</journal><pubmed_title>Prognostic value of glycemic gap in ST-segment elevation myocardial infarction-associated acute kidney injury.</pubmed_title><pmcid>PMC12080177</pmcid><funding_grant_id>2024KY1447</funding_grant_id><funding_grant_id>B20231533</funding_grant_id><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic value of glycemic gap in ST-segment elevation myocardial infarction-associated acute kidney injury.</name><description>&lt;h4>Background&lt;/h4>Stress-induced hyperglycemia (SIH) is a common phenomenon in acute myocardial infarction and is associated with poor prognosis. The relationship between glycemic gap (GG), a marker of SIH, and ST-segment elevation myocardial infarction (STEMI)-associated acute kidney injury (STAAKI) remains unclear. This study aims to explore the predictive value of GG for the risk of STAAKI after percutaneous coronary intervention (PCI) in STEMI patients.&lt;h4>Methods&lt;/h4>This study retrospectively selected patients diagnosed with STEMI who underwent primary PCI. Logistic regression analysis was used to identify the risk factors associated with STAAKI. To examine the dose-response relationship between GG and STAAKI, restricted cubic splines (RCS) were employed. The predictive accuracy of </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-06T16:13:12.985Z</modification><creation>2026-06-02T03:11:33.044Z</creation></dates><accession>S-EPMC12080177</accession><cross_references><pubmed>40375168</pubmed><doi>10.1186/s12882-025-04167-3</doi></cross_references></HashMap>